US Stocks
/
Vera Therapeutics, Inc. Class A Share Price
Vera Therapeutics, Inc. Class A Share Price

Vera Therapeutics, Inc. Class A Share Price

NASDAQ: VERA | Small Cap
$29.81
+$0.04 (0.15%) Last updated on 09 Oct, 2026 | 22:16 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Vera Therapeutics, Inc. Class A Stock Performance

Open
$29.59
Prev. Close
$29.77
Circuit Range
N/A
Day Range
$29.50 - $30.48
Year Range
$23.18 - $56.01
Volume
15,739
Average Traded
$29.91

Vera Therapeutics, Inc. Class A Share Price Today

As of 9 October 2026, Vera Therapeutics, Inc. Class A's share price is $29.81. The stock opened at $29.59, compared to its previous close of $29.77. During today's trading session, Vera Therapeutics, Inc. Class A's share price traded between $29.50 and $30.48, with an average price of $29.99. Over the past 52 weeks, the stock has recorded a high of $56.01 and a low of $23.18. In terms of performance, Vera Therapeutics, Inc. Class A's share price has declined by 16.29% over the last six months and is up 4.87% on a year-on-year basis.

Vera Therapeutics, Inc. Class A Share Price Chart

$29.50$30.48
L
Show Current Price
H

Vera Therapeutics, Inc. Class A Stock Fundamentals & Key Indicators

Market Cap
$1.91B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-5.59
Revenue (TTM)
$0.00
Return On Equity (TTM)
-98.85%
Profit Margin
N/A
Debt to Equity
0.18
Quarterly Earnings Growth YoY
-36.65%

Vera Therapeutics, Inc. Class A Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$80.29-$91.10-$121.97-$109.72
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-13.46%-33.89%10.04%

Vera Therapeutics, Inc. Class A Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$89.06-$95.99-$152.15-$299.62
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-7.78%-58.51%-96.92%

About Vera Therapeutics, Inc. Class A

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Vera Therapeutics, Inc. Class A Historical Returns

MonthOpenCloseChange %
Oct 2026
$32.14
$29.78
-7.97%
Sep 2026
$34.09
$32.36
-6.42%
Aug 2026
$31.41
$34.58
+7.76%
Jul 2026
$42.75
$32.09
-25.25%
Jun 2026
$34.70
$42.93
+20.78%
May 2026
$34.79
$35.55
-0.18%
Apr 2026
$41.01
$35.61
-11.38%
Mar 2026
$40.13
$40.19
-1.53%
Feb 2026
$43.29
$40.81
-5.65%
Jan 2026
$50.74
$43.26
-14.53%
Dec 2025
$33.09
$50.61
+49.53%
Nov 2025
$28.34
$33.84
+19.07%

VERA Share Price FAQs

What is Vera Therapeutics, Inc. Class A share price today?

chevron-up
Vera Therapeutics, Inc. Class A share price today is $29.81 as on October 9, 2026 at 10:16 pm IST.

What is the 52 week high and 52 week low of Vera Therapeutics, Inc. Class A stock?

chevron-up
The 52 week high of Vera Therapeutics, Inc. Class A stock is $56.01, while the 52 week low is $23.18 as of 9 Oct '26.

What is VERA's market capitalisation today?

chevron-up
VERA market capitalisation is $1.91B as of October 9, 2026, at 10:16 pm IST.

What is VERA's net income for the last quarter?

chevron-up
VERA's net income for the last quarter is -109.72B USD.

What is the 5 year returns of VERA?

chevron-up
The 5 year returns of VERA is 54.06% as on 9 Oct '26.

What is the high & low stock price of VERA today?

chevron-up
VERA stock price hit a high of $30.48 and low of $29.50 as of 9 Oct '26.

Can I buy VERA shares in India?

chevron-up
Yes. You can buy VERA in India by opening an international trading account.